A bill to provide for an election of an annuity under section 377 of title 28, United States Code, for any qualified magistrate judge.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,181 other S bills in the 107th — cohort avg 40d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2001 · mid_year · Government Issues
Implementation of medical device laws (S. 1477 and H.R. 3210) Activities related to the medical device regulatory authority of the United States Food and Drug Administration
Client expense: Not reported · Firm income: $100,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2001 · mid_year · Government Issues
Implementation of medical device laws (S. 1477 and H.R. 3210) Activities related to the medical device regulatory authority of the United States Food and Drug Administration
Client expense: Not reported · Firm income: $140,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2001 · mid_year · Government Issues
Implementation of medical device laws (S. 1477 and H.R. 3210) Activities related to the medical device regulatory authority of the United States Food and Drug Administration
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2001 · mid_year · Government Issues
Implementation of medical device laws (S. 1477 and H.R. 3210) Activities related to the medical device regulatory authority of the United States Food and Drug Administration
Client expense: Not reported · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE